T. Rowe Price International Eq Z holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
T. Rowe Price International Equity Index Fund Z Class TLIEX
- NAV / 1-Day Return 22.01 / +1.10 %
- Total Assets 2.7B
-
Adj. Expense Ratio
0.000
- Expense Ratio 0.000
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 3.12%
- Turnover 9%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis TLIEX
Will TLIEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV | 2.87 | 80M | Technology |
MSCI EAFE Index Future Sept 26 | 2.42 | 68M | — |
Trp Government Reserve | 2.19 | 61M | Cash and Equivalents |
HSBC Holdings PLC | 1.56 | 44M | Financial Services |
Roche Holding AG Ordinary Shares new | 1.34 | 38M | Healthcare |
Novartis AG Registered Shares | 1.22 | 34M | Healthcare |
Shell PLC | 1.10 | 31M | Energy |
Nestle SA | 1.10 | 31M | Consumer Defensive |
Mitsubishi UFJ Financial Group Inc | 1.08 | 30M | Financial Services |
AstraZeneca PLC | 1.07 | 30M | Healthcare |